日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

FGFR 家族抑制剂 Futibatinib 治疗儿童横纹肌肉瘤的临床前评估

Jerry T Wu, Adam Cheuk, Kristine Isanogle, Christina Robinson, Xiaohu Zhang, Michele Ceribelli, Erin Beck, Paul Shinn, Carleen Klumpp-Thomas, Kelli M Wilson, Crystal McKnight, Zina Itkin, Hiroshi Sotome, Hiroshi Hirai, Elizabeth Calleja, Volker Wacheck, Brad Gouker, Cody J Peer, Natalia Corvalan, Da

FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma

靶向FGFR4的嵌合抗原受体联合抗髓系多药治疗可有效治疗原位横纹肌肉瘤

Peter M Sullivan #,Rajesh Kumar #,Wei Li,Virginia Hoglund,Lingyan Wang,Yue Zhang,Megan Shi,Dusan Beak,Adam Cheuk,Michael C Jensen   ,Javed Khan,Dimiter S Dimitrov,Rimas J Orentas

CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells

CLPTM1L 促进胰腺癌细胞生长并增强其非整倍性

Jinping Jia, Allen D Bosley, Abbey Thompson, Jason W Hoskins, Adam Cheuk, Irene Collins, Hemang Parikh, Zhen Xiao, Kris Ylaya, Marta Dzyadyk, Wendy Cozen, Brenda Y Hernandez, Charles F Lynch, Jadranka Loncarek, Sean F Altekruse, Lizhi Zhang, Christopher J Westlake, Valentina M Factor, Snorri Thorgei

Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a

系统蛋白质组分析确定转录因子 YY1 是 miR-34a 的直接靶标

Qing-Rong Chen, Li-Rong Yu, Patricia Tsang, Jun S Wei, Young K Song, Adam Cheuk, Joon-Yong Chung, Stephen M Hewitt, Timothy D Veenstra, Javed Khan